Publications
Journal Article (129)
1.
Journal Article
289, 117452 (2025)
Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomers. European Journal of Medicinal Chemistry 2.
Journal Article
377, 144348 (2025)
The neurotoxicity of pesticides: Implications for Parkinson's disease. Chemosphere 3.
Journal Article
Alpha-synuclein in Parkinson's disease: the debate that must go on. Parkinsonism & Related Disorders, 107850 (2025)
4.
Journal Article
20, 34 (2025)
A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies. Molecular Neurodegeneration 5.
Journal Article
16 (6), pp. 1034 - 1042 (2025)
Inhibition of the Parkinson’s Disease-Related Protein DJ-1 by Endogenous Neurotoxins of the 1,2,3,4-Tetrahydroisoquinoline Family. ACS Chemical Neuroscience 6.
Journal Article
Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy. The FEBS Journal (2025)
7.
Journal Article
16 (4), pp. 687 - 698 (2025)
Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach. ACS Chemical Neuroscience 8.
Journal Article
Protein misfolding: understanding biology to classify and treat synucleinopathies. Journal of Neural Transmission (2025)
9.
Journal Article
21 (2), e14449 (2025)
Initial biological classification of Lewy body diseases: No consensus on terminology. Alzheimer's & Dementia 10.
Journal Article
268, 116880 (2025)
α-Synuclein plastic antibody applied to monitor monomeric structures and discriminate aggregated forms in human CSF. Biosensors and Bioelectronics 11.
Journal Article
476, 115269 (2025)
Correlational assessment of the effects of JM-20 in a rat model of parkinsonism. Behavioural Brain Research 12.
Journal Article
7 (2), fcaf133 (2025)
Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis. Brain Communications 13.
Journal Article
131, 103969 (2024)
SUMOylation modulates mitochondrial dynamics in an in vitro rotenone model of Parkinson's disease. Molecular and Cellular Neuroscience 14.
Journal Article
13 (11), 939 (2024)
Dose-Dependent Cognitive Decline, Anxiety, and Locomotor Impairments Induced by Doxorubicin: Evidence from an Animal Model. Biology 15.
Journal Article
64 (21), pp. 8215 - 8226 (2024)
Impact of Phosphorylation on the Physiological Form of Human alpha-Synuclein in Aqueous Solution. Journal of Chemical Information and Modeling 16.
Journal Article
8 (1), pp. 83 - 98 (2024)
Stress granules formation in HEI-OC1 auditory cells and in H4 human neuroglioma cells secondary to cisplatin exposure. Cell Stress 17.
Journal Article
25 (20), e202400253 (2024)
Synthesis and Semi-Synthesis of Alpha-Synuclein: Insight into the Chemical Complexity of Synucleinopathies. Chembiochem 18.
Journal Article
One-step nanoscale expansion microscopy reveals individual protein shapes. Nature Biotechnology (2024)
19.
Journal Article
32 (10), pp. 3372 - 3401 (2024)
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease. Molecular Therapy 20.
Journal Article
20 (10), pp. 6776 - 6792 (2024)
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin‐1 causing cellular dysfunctions in vitro and in vivo. Alzheimer's & Dementia 21.
Journal Article
364, 143039 (2024)
A versatile yeast model identifies the pesticides cymoxanil and metalaxyl as risk factors for synucleinopathies. Chemosphere 22.
Journal Article
168 (8), pp. 1608 - 1624 (2024)
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry 23.
Journal Article
168 (8), pp. 1514 - 1526 (2024)
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry 24.
Journal Article
168 (8), pp. 1625 - 1639 (2024)
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry 25.
Journal Article
14 (5), pp. 917 - 924 (2024)
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms. Journal of Parkinson's Disease 26.
Journal Article
23 (7), p. 669 (2024)
Abandon the NAC in α-synuclein. Lancet Neurology 27.
Journal Article
18, 1412450 (2024)
Age-related alterations in efferent medial olivocochlear-outer hair cell and primary auditory ribbon synapses in CBA/J mice. Frontiers in Cellular Neuroscience 28.
Journal Article
14 (4), pp. 681 - 692 (2024)
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease: JPD 29.
Journal Article
39 (6), pp. 1080 - 1081 (2024)
Reply to: “Rethinking Parkinson's Disease: A Syndromic Perspective”. Movement Disorders 30.
Journal Article
39 (6), pp. 929 - 933 (2024)
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders 31.
Journal Article
49, pp. 1643 - 1654 (2024)
Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson’s Disease. Neurochemical Research 32.
Journal Article
122, 106078 (2024)
Towards a biological diagnosis of PD. Parkinsonism & Related Disorders 33.
Journal Article
23 (5), e14128 (2024)
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell 34.
Journal Article
39 (4), pp. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 35.
Journal Article
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 36.
Journal Article
31, pp. 3797 - 3804 (2024)
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose 37.
Journal Article
22, pp. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 38.
Journal Article
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry 39.
Journal Article
121 (2), e2309700120 (2024)
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. PNAS 40.
Journal Article
13 (1), e6900 (2024)
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine 41.
Journal Article
147 (1), pp. 81 - 90 (2024)
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain 42.
Journal Article
147 (1), 40 (2024)
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica 43.
Journal Article
18, pp. 68 - 71 (2024)
Prion meeting 2023: implications of a growing field. Prion 44.
Journal Article
1869 (8), 166835 (2023)
Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta-Molecular Basis of Disease 45.
Journal Article
146, pp. 369 - 385 (2023)
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica 46.
Journal Article
166 (5), pp. 862 - 874 (2023)
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry 47.
Journal Article
38 (9), pp. 1585 - 1597 (2023)
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis. Movement Disorders 48.
Journal Article
24 (17), 13435 (2023)
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 49.
Journal Article
29 (1), 111 (2023)
The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine 50.
Journal Article
39 (4-6), pp. 321 - 335 (2023)
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease. Antioxidants & redox signaling